General Information of Drug (ID: DMITYCN)

Drug Name
PF-3557156 Drug Info
Synonyms PDE 7 inhibitor (pain), Pfizer; Phosphodiesterase 7 inhibitor (pain), Pfizer
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Discontinued in Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMITYCN

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SCH51866 DMCWSJP Discovery agent N.A. Investigative [3]
BRL50481 DMV2XUM Discovery agent N.A. Investigative [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Phosphodiesterase 7A (PDE7A) TT1BC3A PDE7A_HUMAN Modulator [2]
Phosphodiesterase 7B (PDE7B) TTWIEY9 PDE7B_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026842)
2 Company report (Pfizer pipeline: October 28, 2008)
3 Identification of human PDE7B, a cAMP-specific phosphodiesterase. Biochem Biophys Res Commun. 2000 May 19;271(3):575-83.
4 New classes of PDE7 inhibitors identified by a fission yeast-based HTS. J Biomol Screen. 2010 Apr;15(4):359-67.